Provided by Tiger Trade Technology Pte. Ltd.

Allarity Therapeutics Inc

1.17
-0.0600-4.88%
Volume:63.57K
Turnover:75.66K
Market Cap:18.51M
PE:-1.62
High:1.26
Open:1.20
Low:1.17
Close:1.23
52wk High:2.35
52wk Low:0.7687
Shares:15.82M
Float Shares:15.79M
Volume Ratio:1.44
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7218
EPS(LYR):-0.7811
ROE:-87.92%
ROA:-23.70%
PB:2.67
PE(LYR):-1.50

Loading ...

Allarity Therapeutics announces annual shareholder meeting

Reuters
·
Apr 11

BRIEF-Allarity Therapeutics Reports Full Year 2025 Financial Results And Corporate Progress

Reuters
·
Mar 31

Allarity FY25 net loss narrows to $11 million; revenue rises to $0.3 million

Reuters
·
Mar 31

Allarity Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
Mar 27

Allarity Therapeutics Closes $20 Million Non-Convertible Debt Financing With Streeterville Capital

Reuters
·
Mar 06

BRIEF-Allarity Therapeutics Closes $20 Million Financing To Accelerate The Advance Of Stenoparib Toward FDA Approval And Commercialization

Reuters
·
Mar 06

Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization

THOMSON REUTERS
·
Mar 06

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Relapsed SCLC Trial of Stenoparib Plus Temozolomide

Reuters
·
Feb 18

Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need

GlobeNewswire
·
Feb 18

Allarity Therapeutics Inc - Prospectus for Resale of 255,103 Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Feb 13

Allarity announce enrollment open for Phase 2 trial of stenoparib, temozolomide

TIPRANKS
·
Feb 03

Allarity Therapeutics Announces That Its Collaborative Phase 2 Trial With the United States Veteran’s Administration Combining Stenoparib With Temozolomide in Relapsed Small Cell Lung Cancer Is NOW Open for Enrollment

THOMSON REUTERS
·
Feb 03

Allarity Therapeutics Partners with U.S. Department of Veterans Affairs for Phase 2 Cancer Trial

Reuters
·
Feb 03

Allarity Therapeutics Inc - on Jan 28, Co Entered Stock Purchase Agreement With Tumim Stone Capital - SEC Filing

THOMSON REUTERS
·
Jan 29

Allarity Therapeutics Inc - Company May Sell up to $6 Mln in Newly Issued Shares - SEC Filing

THOMSON REUTERS
·
Jan 29